Heide Hassing

Statistics

Publications

Citations

895

H-Index

Active since

2000

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Heide Hassing is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in inflammation, atherosclerosis molecular mechanisms, and atherosclerotic progression.

Publications per year

2000–2002

Publications

Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol Lowering

Carl P. Sparrow, Charlotte Burton, Melba Hernandez et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2001 · 414 citations

Medicine, Pharmacology, Pharmacotherapy +17

Deficiency in Inducible Nitric Oxide Synthase Results in Reduced Atherosclerosis in Apolipoprotein E-Deficient Mice

Patricia A. Detmers, Melba Hernandez, John S. Mudgett et al. · The Journal of Immunology · 2000 · 209 citations · Full text

Life Sciences, Cardiology, Inflammation +12

Infectious Agents Are Not Necessary for Murine Atherogenesis

Samuel D. Wright, Charlotte Burton, Melba Hernandez et al. · The Journal of Experimental Medicine · 2000 · 176 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

ApoE−/− Mice Develop Atherosclerosis in the Absence of Complement Component C5

Sushma Patel, Erin M. Thelander, Melba Hernandez et al. · Biochemical and Biophysical Research Communications · 2001 · 69 citations

Life Sciences, Immunology, Pathology +13

Simvastatin has anti-inflammatory and anti-atherosclerotic activities independent of plasma cholesterol-lowering

Carl P. Sparrow, Charlotte Burton, M.-A.M. Hernandez et al. · Atherosclerosis · 2000 · 17 citations

Medicine, Cardiology, Pharmacology +14

1–5 of 6